Showing results (181-190 of 240) with videos related to
Sort By:
Pageof 24
BMC Neurology|January 16, 2009
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic reviewHannah A D Keage, Roxanna O Carare, Robert P Friedland, et al.The Journal of Pathology|November 29, 2014
Effect of active Aβ immunotherapy on neurons in human Alzheimer's diseaseClaire Paquet, Jay Amin, François Mouton-Liger, et al.Research Square|May 3, 2023
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's diseaseJames Miners, Carol van Hulle, Selvi Ince, et al.American Journal of Neurodegenerative Disease|April 23, 2014
Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissueSeth Love, Katy Chalmers, Paul Ince, et al.Stroke|February 24, 2022
Iron Deposition in the Brain After Aneurysmal Subarachnoid HemorrhageIan Galea, Andrew Durnford, James Glazier, et al.Translational Psychiatry|January 5, 2024
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's diseaseCarol Van Hulle, Selvi Ince, Ozioma C Okonkwo, et al.Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.Journal of Alzheimer'S Disease : JAD|July 16, 2014
Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodiesStewart F Graham, Muhammad Bin Nasaruddin, Manus Carey, et al.Journal of Alzheimer'S Disease : JAD|November 2, 2014
Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodiesStewart F Graham, Muhammad Bin Nasarauddin, Manus Carey, et al.Neurobiology of Aging|December 11, 2007
TNFR-associated factor-2 (TRAF-2) in Alzheimer's diseaseDoris Culpan, Dougal Cram, Kate Chalmers, et al.Pageof 24